Yield10 Bioscience Inc
OTC:YTENQ

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
OTC:YTENQ
Watchlist
Price: 0.0001 USD
Market Cap: 1 USD

Yield10 Bioscience Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Yield10 Bioscience Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Yield10 Bioscience Inc
OTC:YTENQ
Revenue
$750k
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
-9%
Abbvie Inc
NYSE:ABBV
Revenue
$59.6B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$29.1B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Amgen Inc
NASDAQ:AMGN
Revenue
$36B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$11.7B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$14.2B
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
14%
No Stocks Found

Yield10 Bioscience Inc
Glance View

Market Cap
1 USD
Industry
Biotechnology

Yield10 Bioscience, Inc. operates as an agricultural bioscience company. The company is headquartered in Woburn, Massachusetts and currently employs 29 full-time employees. The company went IPO on 2006-11-10. The firm is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low-carbon sustainable seed products. The firm focuses on petroleum replacement markets, in which it is developing Camelina oil for use as a biofuel feedstock and polyhydroxyalkanoates (PHA) bioplastics produced in Camelina seed for use as a biodegradable bioplastic; and food and nutrition markets, in which it is developing omega-3 (DHA+EPA) oils produced in Camelina seed for aquaculture, nutraceuticals and protein meal for animal feed markets. The company is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits that form improved elite Camelina varieties for the biofuel market. The firm's new seed product traits include the PHA bioplastic trait developed by the Company and the omega-3 (DHA+EPA) oil traits.

YTENQ Intrinsic Value
Not Available

See Also

What is Yield10 Bioscience Inc's Revenue?
Revenue
750k USD

Based on the financial report for Jun 30, 2024, Yield10 Bioscience Inc's Revenue amounts to 750k USD.

What is Yield10 Bioscience Inc's Revenue growth rate?
Revenue CAGR 10Y
-9%

Over the last year, the Revenue growth was 188%. The average annual Revenue growth rates for Yield10 Bioscience Inc have been -1% over the past three years , 3% over the past five years , and -9% over the past ten years .

Back to Top